ZeroCancer.com – fight cancer through knowledge

Cancer news

Despite huge strides in treatment over the past four decades, cancer remains the second leading cause of death in the United States, claiming the lives of 560,000 people last year, a report said Tuesday.
US doctors and scientists have made huge strides in the fight against cancer in the past four decades, slashing the death rate by nearly 16 percent, a report published Tuesday showed.
TUESDAY, March 16 (HealthDay News) -- Researchers have succeeded in freezing away breast and prostate tumors in a small number of patients, opening a promising door to a new generation of cancer treatments.
The death rate from all cancers fell by almost 16 percent from 1991 to 2006, the editorial said. Much of that decline came from anti-smoking campaigns and early disease detection, said the commentary by researchers at the American Cancer Society in Atlanta.
The U.S. government has spent $100 billion funding cancer research since then-President Richard Nixon declared the ?War on Cancer? in 1971, says an editorial in the Journal of the American Medical Association.
Dr. Jennifer Ashton Discusses Most Common Cancer, Risk Factors, When to Go to the Doctor
THE QUESTION Women who have cancer in one breast sometimes have the other breast removed as a preventive measure. Does this improve their chances of living longer?
Men who start going bald at a young age are up to 45% less likely to get prostate cancer in later life, a study has found.
The Lockerbie bomber is at the center of a fresh row after it emerged he is taking a cancer drug that could keep him alive for five more years, The Sun reported on Monday.
Going against the grain, U.S. Wellness Meats says its grass-fed steaks and chops can fight cancer and heart disease, as well as hunger

Delayed surgery decreases bladder cancer survival

NEW YORK (Reuters Health) - For patients newly diagnosed with bladder cancer, delays of more than 3 months after the initial diagnosis to surgery results in decreased survival, a study shows.

“There currently are no standardized guidelines for the appropriate timing of cystectomy” (surgical removal of the bladder), Dr. Cheryl T. Lee from University of Michigan, Ann Arbor, Michigan told Reuters Health. “However, there is growing evidence that cystectomy should be performed within 3 months of a diagnosis” of muscle-invasive disease.

The current study, she said, supports that “patients must undergo cystectomy within 3 months of diagnosis or their survival may be compromised.”

Lee and colleagues evaluated the timing from the diagnosis of bladder cancer to cystectomy in 214 consecutive patients to assess its impact on survival.

By investigating each delay duration, the authors were able to identify a delay of 93 days as the first cutoff point that resulted in a significantly decreased overall survival and so-called disease-specific survival.

Three-year disease-specific survival was 62 percent for patients who underwent cystectomy within 93 days of diagnosis and 49 percent for those who underwent surgery later, the researchers note.

Three-year overall survival was 51 percent and 38 percent, respectively, for patients operated within and beyond 93 days of diagnosis.

Patients who had a cystectomy delay of more than 93 days faced about twice the risk of patients who had an earlier cystectomy of dying from any cause or from bladder cancer, according to a multivariate analysis.

Nearly half the scheduling delays in patients who underwent cystectomy after 93 days were related to clinical or research appointments, the investigators say. Patient co-morbidities accounted for 15 percent of the delays, and difficulty with decision-making contributed to 12 percent of the delays.

“Rigorous coordination of preoperative counseling, medical clearance, and patient education is required to permit an efficient decision-making process and timely delivery of surgery,” Lee said.

SOURCE: The Journal of Urology April 2006.

Tags:

▼ Show related feed